Nurix Therapeutics, Inc.
Nurix Therapeutics develops targeted protein degradation medicines for cancer and autoimmune diseases.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 3Latest story
Nurix Therapeutics develops targeted protein degradation medicines for cancer and autoimmune diseases.